Demographic Data |
Relation to Proband |
proband |
Age at Sampling |
4 YR |
Sex |
Male |
Age of Onset(If not a control) |
1 YR |
Age at Diagnosis(If not a control) |
3 YR |
Racial Category |
White |
Country |
GERMANY |
|
Data Elements |
Clinical Element Type: General NIGMS Catalog Remarks |
(Baseline) |
Mutation Information |
Gene, variant, consequence, and exon number: |
SLC6A8, C.1260_1281DEL, P.GLY421ALAFSTER35, FRAMESHIFT |
Zygosity: |
Hemizygous |
Age of Symptom Onset and Age at Diagnosis |
Age of Symptom Onset: |
1 YEAR |
Age at Diagnosis: |
3 YEARS |
In Utero History Information |
|
|
Birth History Information |
|
|
Dysmorphic Features |
|
Microcephaly
|
Neurological Symptoms |
|
Hypotonia Seizures White matter issues
|
Additional Information: |
INCOMPLETE MYELINATION OF THE SUPRATENTORIAL WHITE MANNER
GAIT ABNORMALITY
NO SEIZURE WITHOUT AN EXTERNAL CAUSE AND WITHOUT EXCITEMENT |
Optical and Audiological Symptoms |
|
|
Musculoskeletal Symptoms |
|
|
Additional Information: |
FLAT FEET
JOINT HYPERMOBILITY |
Developmental Milestones |
|
Delayed speech and language development Delayed fine motor skills
|
Running: |
Achieved and maintained |
Additional Information: |
PSYCHOMOTOR RETARDATION
FIRST WORD AT 2.5 YEARS OF AGE
FREE RUN AT 2 YEARS OF AGE
SPEAKING 2-WORD SENTENCES WITH A VOCABULARY OF 200 WORDS |
Gastrointestinal Symptoms |
|
Constipation
|
Genitourinary Symptoms |
|
|
Respiratory and Cardiovascular Symptoms |
|
|
Cognitive and Behavioral Symptoms |
|
Happy personality Behavioral problems
|
Additional Information: |
MENTAL IMPAIRMENT
IMPULSE CONTROL DISORDER WITH SCREAMING ATTACKS AND SYNCOPE
BELOW AVERAGE COGNITIVE PERFORMANCE LEVEL |
Additional Information |
Testing Performed |
Neurological Testing: |
MRI: MASSIVELY REDUCED CREATINE RESPONSE; NARROW BAR, VAGUE SIGNAL INCREASE
EEG: GENERALIZED ABNORMAL BEAT ACTIVITY; NO EVIDENCE OF EPILEPSY; PATHOLOGICAL WAKEFULNESS-TIREDNESS-SLEEP UP TO STAGE 3, DUE TO MASSIVE FOCAL HSA IN THE FORM OF AMPLITUDE-HISH SHARP SLOW WAVES WITH MAXIMUM RIGHT OARIETO-OCCIPITAL. THERE IS ALSO PHASE REVERSAL. |
Cognitive and Behavioral Testing: |
COGNITIVE DEVELOPMENT AROUND 24-26 MONTHS WHEN TESTED AT 3 YEARS AND 9 MONTHS |
Metabolic, Hematologic, and Endocrinologic Testing: |
URINE CREATINE: 253.4 UMOL/KG/24H (H)
URINE PH 8.5 (H)
URINE LEUKOCYTE 54.0 (H) |
Treatments and Assistive Devices |
|
Occupational therapy Physical therapy Speech therapy horseback therapy
|
Medications |
|
MOVICOL JUNIOR, CREATINE, GLYCINE, ARGININE |
Family History |
|
MUTATION INHERITED FROM MOSAIC CARRIER MOTHER |
Remarks |
Clinically affected. See "Phenotypic Data" tab; making good progress with current therapy. Fibro is GM28292; Unaffected mother is GM28293 and GM28295. |